Victoria C Yan

18PUBLICATIONS
24CO-AUTHORS
NaturopathyRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 17, 2026
A is for ___ : Narrative Medicine Framework for Mental Health Empowerment and Self-Authorship in Asian American Communities.

|May 18, 2026
Uremic pancreatitis following routine initiation of losartan in advanced chronic kidney disease: A case report.

|Mar 28, 2024
Correction: Cook et al. An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats. Viruses 2022, 14, 2429.

Sarah Cook, Luke Wittenburg, Victoria C Yan

|Feb 17, 2023
Comparative Pharmacology of a Bis-Pivaloyloxymethyl Phosphonate Prodrug Inhibitor of Enolase after Oral and Parenteral Administration.

Victoria C Yan, Yasaman Barekatain, Yu-Hsi Lin

|Nov 11, 2022
An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats.

Sarah Cook, Luke Wittenburg, Victoria C Yan

|Oct 17, 2022
Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of ENO1-Deleted Cancers.

Victoria C Yan, Cong-Dat Pham, Elliot S Ballato

Pageof 3

Frequent Collaborators

4 joint publications

Yasaman Barekatain

4 joint publications

Florian L Muller

3 joint publications

Nikunj Satani

3 joint publications

Steven W Millward